The role of tumour budding at the front of invasion and recurrence of rectal carcinoma

Anticancer Research

Volumn 25, Issue 2 B, 2005, Pages 1269-1272

  Guzińska Ustymowicz, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Invasion; Rectal carcinoma; Tumour budding

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CARCINOMA;

BIOPSY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 17444413409     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Guzińska-Ustymowicz K, Sulkowska M, Famulski W and Sulkowski S: Tumour budding and its relationship to p53 and bcl-2 expession in colorectal cancer. Anticancer Res 23: 649-654, 2003.
2. Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Sakamoto A and Atomi Y: Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas. Anticancer Res 23: 4169-4174, 2003.
3. Masaki T, Matsuoka H, Sugiyama M, Abe N, Izumisato Y, Goto A, Sakamoto A and Atomi Y: Laminin-5γ2 chain and matrix metalloproteinase-2 may trigger colorectal carcinoma invasiveness through formation of budding tumor cells. Anticancer Res 23: 4113-4120, 2003.
4. Zheng CX, Zhan WH, Zhao JZ, Zheng D, Wang DP, He YL and Zheng ZQ: The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World J Gastroenterol 7: 431-434, 2001.
5. Peng ZH, Xing TH, Qiu GQ and Tang HM: Relationship between Fas/Fasl expression and apoptosis in colon adenocarcinoma cell lines. World J Gastroenterol 7: 88-92, 2001.
6. Ueno H, Murphy J, Jass JR, Mochizuki H and Talbot IC: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002.
7. Dukes CE and Bussey HJR: The spread of rectal cancer and its effect on prognosis. Br J Surg 12: 309-320, 1958.
8. Astler VB and Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846-852, 1954.
9. Hutter RVP and Sobin LH: A universal staging system for cancer of the colon and rectum. Arch Pathol Lab Med 110: 367-368, 1986.
10. Compton C, Fenoglio-Preiser CM, Pettigrew N and Fleding LP: American Joint Committee on Cancer prognostic factors consensus conference colorectal working group. Cancer 88: 1739-1757, 2000.
11. Jass JR, Love SB and Northover JM: A new prognostic classification of rectal cancer. Lancet 2: 1303-1306, 1987.
12. Morodomi T, Isomoto H, Shirouzu G, Shirouzu K, Kakegawa K, Irie K and Morimatsu M: An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancers. Cancer 63: 539-43, 1989.
13. Okuyama T, Oya M and Ishikawa H: Budding as a risk factor for lymph node metastasis in T1 or T2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 45: 628-634, 2002.
14. Hase K, Shatney C, Johnson D, Trollope M and Vierra M: Prognostic value of tumor budding in patients with colorectal cancer. Dis Colon Rectum 36: 627-635, 1993.
15. Tanaka M, Hashiguchi Y, Ueno H, Hase K and Mochizuki H: Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 46: 1054-1059, 2003.